1. Market Research
  2. > Meridian Bioscience, Inc. (VIVO) - Financial and Strategic SWOT Analysis Review

Meridian Bioscience, Inc. (VIVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Meridian Bioscience, Inc. (Meridian) is a fully integrated life science company that carries out the development, manufacturing and distribution of diagnostic test kits for gastrointestinal, viral, respiratory, and parasitic infectious disease indications. It also manufactures bulk antigens, antibodies, purified reagents, nucleotides and related products for use in research and diagnostic manufacturing. Meridian develops proteins and other biological materials for use in biotechnology research for new drugs and vaccines. It has o several diagnostic tests and transport media, spanning from prenatal care, respiratory infections, and organ transplant infections among other infectious disease areas. Meridian offers its products to hospitals, clinics, veterinary testing centers, reference laboratories, research centers, physician offices and diagnostics manufacturers. The company has presence in the US, Europe, Africa and the Middle East through direct offices and subsidiaries. Meridian is headquartered in Ohio, the US.

Meridian Bioscience, Inc. Key Recent Developments

Dec 09, 2015: Bioline Launches New JetSeq DNA Library Preparation Kit
Nov 05, 2015: Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2016 Guidance
Sep 09, 2015: Meridian Bioscience Provides Net Revenues and Earnings Guidance for Fiscal 2016
Sep 04, 2015: BioLineRx Launches New EPIK miRNA Panel Assays
Aug 17, 2015: Meridian Bioscience Elects Catherine Sazdanoff and John McIlwraith to the Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table Of Contents

Meridian Bioscience, Inc. (VIVO) - Financial and Strategic SWOT Analysis Review
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 - About the Company 6
Meridian Bioscience, Inc. - Key Facts 6
Meridian Bioscience, Inc. - Key Employees 7
Meridian Bioscience, Inc. - Key Employee Biographies 8
Meridian Bioscience, Inc. - Major Products and Services 9
Meridian Bioscience, Inc. - Medical Equipment Pipeline Products Data 12
Meridian Bioscience, Inc. Pipeline Products by Equipment Type 12
Meridian Bioscience, Inc. Pipeline Products by Development Stage 13
Meridian Bioscience, Inc. - History 14
Meridian Bioscience, Inc. - Company Statement 19
Meridian Bioscience, Inc. - Locations And Subsidiaries 21
Head Office 21
Other Locations and Subsidiaries 21
Meridian Bioscience, Inc. - Key Manufacturing Facilities 23
Section 2 - Company Analysis 24
Meridian Bioscience, Inc. - Business Description 24
Meridian Bioscience, Inc. - Corporate Strategy 25
Meridian Bioscience, Inc. - SWOT Analysis 26
SWOT Analysis - Overview 26
Meridian Bioscience, Inc. - Strengths 26
Strength - Diagnostics Segment 26
Strength - Established Presence in North America 26
Strength - Research and Development Activities 26
Meridian Bioscience, Inc. - Weaknesses 27
Weakness - Reliance on a Few Distributors 27
Meridian Bioscience, Inc. - Opportunities 28
Opportunity - Growing IVD Market 28
Opportunity - Growing Market for Infectious Disease Tests 28
Opportunity - Regulatory Approvals and New Product Lauches 28
Opportunity - Investment in Oasis Diagnostics 28
Meridian Bioscience, Inc. - Threats 29
Threat - Integration of Acquisitions 29
Threat - Government Regulations 29
Threat - Intense Competition 29
Meridian Bioscience, Inc. - Key Competitors 30
Section 3 - Company Financial Ratios 31
Financial Ratios - Capital Market Ratios 31
Financial Ratios - Annual Ratios 32
Performance Chart 34
Financial Performance 34
Financial Ratios - Interim Ratios 35
Financial Ratios - Ratio Charts 36
Section 4 - Company's Lifesciences Financial Deals and Alliances 37
Meridian Bioscience, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 37
Meridian Bioscience, Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016 38
Meridian Bioscience, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 39
Meridian Bioscience, Inc., Pharmaceuticals and Healthcare, Deals By Type, 2010 to YTD 2016 40
Meridian Bioscience, Inc., Recent Deals Summary 41
Section 5 - Company's Recent Developments 42
Jan 26, 2016: New Malaria Test, illumigene Malaria, Sets a New Gold Standard for Diagnosis 42
Jan 26, 2016: Meridian Bioscience and Lean Continuous Improvements Collaborate to Apply Lean Principles to Recent Launch of illumigene Malaria 43
Jan 26, 2016: Meridian Bioscience and Lean Continuous Improvements, Collaborate to Apply Lean Principles to Recent Launch of illumigene Malaria 44
Dec 09, 2015: Bioline Launches New JetSeq DNA Library Preparation Kit 45
Nov 18, 2015: Meridian Receives FDA Clearance For New Molecular Whooping Cough Test Claims 46
Nov 05, 2015: Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2016 Guidance 47
Sep 09, 2015: Meridian Bioscience Provides Net Revenues and Earnings Guidance for Fiscal 2016 49
Sep 04, 2015: BioLineRx Launches New EPIK miRNA Panel Assays 50
Aug 17, 2015: Meridian Bioscience Elects Catherine Sazdanoff and John McIlwraith to the Board of Directors 51
Jul 23, 2015: Meridian Bioscience Reports Third Quarter and Nine Months Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2015 Guidance 52
Section 6 - Appendix 54
Methodology 54
Ratio Definitions 54
About GlobalData 58
Contact Us 58
Disclaimer 58

List of Tables
Meridian Bioscience, Inc., Key Facts 6
Meridian Bioscience, Inc., Key Employees 7
Meridian Bioscience, Inc., Key Employee Biographies 8
Meridian Bioscience, Inc., Major Products and Services 9
Meridian Bioscience, Inc. Number of Pipeline Products by Equipment Type 12
Meridian Bioscience, Inc. Pipeline Products by Equipment Type 12
Meridian Bioscience, Inc. Number of Pipeline Products by Development Stage 13
Meridian Bioscience, Inc. Pipeline Products by Development Stage 13
Meridian Bioscience, Inc., History 14
Meridian Bioscience, Inc., Other Locations 21
Meridian Bioscience, Inc., Subsidiaries 21
Meridian Bioscience, Inc., Key Manufacturing Facilities 23
Meridian Bioscience, Inc., Key Competitors 30
Meridian Bioscience, Inc., Ratios based on current share price 31
Meridian Bioscience, Inc., Annual Ratios 32
Meridian Bioscience, Inc., Interim Ratios 35
Meridian Bioscience, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 37
Meridian Bioscience, Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016 38
Meridian Bioscience, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 39
Meridian Bioscience, Inc., Pharmaceuticals and Healthcare, Deals By Type, 2010 to YTD 2016 40
Meridian Bioscience, Inc., Recent Deals Summary 41
Currency Codes 54
Capital Market Ratios 54
Equity Ratios 55
Profitability Ratios 55
Cost Ratios 56
Liquidity Ratios 56
Leverage Ratios 57
Efficiency Ratios 57

List of Figures
Meridian Bioscience, Inc. Pipeline Products by Equipment Type 12
Meridian Bioscience, Inc. Pipeline Products by Development Stage 13
Meridian Bioscience, Inc., Performance Chart (2011 - 2015) 34
Meridian Bioscience, Inc., Ratio Charts 36
Meridian Bioscience, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 37
Meridian Bioscience, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 38
Meridian Bioscience, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 39
Meridian Bioscience, Inc., Pharmaceuticals and Healthcare, Deals by Type, 2010 to YTD 2016 40

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.